Career history of Donald C. Fresne
Former positions of Donald C. Fresne
| Companies | Position | Start | End |
|---|---|---|---|
Egenix, Inc.
 Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Director/Board Member | - | 16/04/2020 |
| Chief Executive Officer | 24/07/2011 | 18/12/2014 | |
| President | 24/07/2011 | 18/12/2014 | |
Epigen, Inc.
 Epigen, Inc. Medical SpecialtiesHealth Technology Epigen, Inc. develops products to monitor, diagnose and treat cancer n a more effective, less expensive and less invasive manner than other products currently available. The company is in the process of completing the development of its in-vitro blood test, a confirmatory test for prostate cancer. This employs the use of the HC Antigen. It was founded on April 24, 1991. | Chairman | 04/03/2010 | 22/09/2010 |
| President | 04/03/2010 | 22/09/2010 |
Statistics
International
| United States | 3 |
Operational
| President | 2 |
| Chairman | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Epigen, Inc.
Epigen, Inc. Medical SpecialtiesHealth Technology Epigen, Inc. develops products to monitor, diagnose and treat cancer n a more effective, less expensive and less invasive manner than other products currently available. The company is in the process of completing the development of its in-vitro blood test, a confirmatory test for prostate cancer. This employs the use of the HC Antigen. It was founded on April 24, 1991. | Health Technology |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Health Technology |
- Stock Market
- Insiders
- Donald C. Fresne
- Experience
